Live feed07:00:00·682dPRReleasevia QuantisnowOcular Therapeutix™ Announces FDA Feedback That SOL-R Trial is Appropriate as a Registrational Study in Wet AMDByQuantisnow·Wall Street's wire, on your screen.OCUL· Ocular Therapeutix Inc.Health Care
